Selective Delivery of a Therapeutic Gene for Treatment of Head and Neck Squamous Cell Carcinoma Using Human Neural Stem Cells
Seong Keun Kwon, Seung U Kim, Jae-Jun Song, Chang Gun Cho, Seok-Won Park
Clin Exp Otorhinolaryngol. 2013;6(3):176-183.   Published online 2013 Sep 4     DOI:
Citations to this article as recorded by Crossref logo
Prodrugs and prodrug-activated systems in gene therapy
Semira Sheikh, Daniel Ernst, Armand Keating
Molecular Therapy.2021; 29(5): 1716.     CrossRef
Intravenously Infused Stem Cells for Cancer Treatment
Alison R. Mercer-Smith, Ingrid A. Findlay, Hunter N. Bomba, Shawn D. Hingtgen
Stem Cell Reviews and Reports.2021; 17(6): 2025.     CrossRef
A highly efficient non-viral process for programming mesenchymal stem cells for gene directed enzyme prodrug cancer therapy
Yoon Khei Ho, Jun Yung Woo, Geraldine Xue En Tu, Lih-Wen Deng, Heng-Phon Too
Scientific Reports.2020;[Epub]     CrossRef
Combined treatment, based on lysomustine administration with mesenchymal stem cells expressing cytosine deaminase therapy, leads to pronounced murine Lewis lung carcinoma growth inhibition
Lyudmila S. Krassikova, Saida S. Karshieva, Ivan B. Cheglakov, Alexander V. Belyavsky
The Journal of Gene Medicine.2016; 18(9): 220.     CrossRef
Mesenchymal stem cells expressing cytosine deaminase inhibit growth of murine melanoma B16F10 in vivo
L. S. Krasikova, S. S. Karshieva, I. B. Cheglakov, A. V. Belyavsky
Molecular Biology.2015; 49(6): 904.     CrossRef